Adequate Lymph Node Assessment for Extrahepatic Bile Duct Adenocarcinoma
暂无分享,去创建一个
M. Gonen | M. D'Angelica | W. Jarnagin | R. DeMatteo | D. Klimstra | P. Allen | M. Brennan | Y. Fong | L. Blumgart | Hiromichi Ito | Kaori Ito
[1] R. Jenkins,et al. Proximal biliary malignancy. , 2008, The Surgical clinics of North America.
[2] G. Veillette,et al. Distal biliary malignancy. , 2008, The Surgical clinics of North America.
[3] M. Gonen,et al. Extrahepatic cholangiocarcinoma: a comparison of patients with resected proximal and distal lesions. , 2008, HPB : the official journal of the International Hepato Pancreato Biliary Association.
[4] I. Endo,et al. Clinical Significance of Intraoperative Bile Duct Margin Assessment for Hilar Cholangiocarcinoma , 2008, Annals of Surgical Oncology.
[5] M. Gönen,et al. Prognostic Significance of Pathologic Nodal Status in Patients with Resected Pancreatic Cancer , 2007, Journal of Gastrointestinal Surgery.
[6] M. Choti,et al. Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer. , 2007, Surgery.
[7] Steven C Cunningham,et al. Cholangiocarcinoma: Thirty-one-Year Experience With 564 Patients at a Single Institution , 2007, Annals of surgery.
[8] David D. Smith,et al. Lymph Node Dissection Impact on Staging and Survival of Extrahepatic Cholangiocarcinomas, Based on U.S. Population Data , 2007, Journal of Gastrointestinal Surgery.
[9] L. Ben-Porat,et al. Papillary Phenotype Confers Improved Survival After Resection of Hilar Cholangiocarcinoma , 2005, Annals of surgery.
[10] G. Leonard,et al. Biliary tract cancers: current concepts and controversies , 2005, Expert opinion on pharmacotherapy.
[11] Murray F. Brennan,et al. Prognostic Nomogram for Patients Undergoing Resection for Adenocarcinoma of the Pancreas , 2004, Annals of surgery.
[12] M. Gonen,et al. Staging, Resectability, and Outcome in 225 Patients With Hilar Cholangiocarcinoma , 2001, Annals of surgery.
[13] M. Nagino,et al. Lymph Node Metastasis from Hilar Cholangiocarcinoma: Audit of 110 Patients Who Underwent Regional and Paraaortic Node Dissection , 2001, Annals of surgery.
[14] D. Klimstra,et al. Lymph Node Staging in Gastric Cancer: Is Location More Important Than Number?: An Analysis of 1,038 Patients , 2000, Annals of surgery.
[15] C C Compton,et al. Updated protocol for the examination of specimens from patients with carcinomas of the colon and rectum, excluding carcinoid tumors, lymphomas, sarcomas, and tumors of the vermiform appendix: a basis for checklists. Cancer Committee. , 2000, Archives of pathology & laboratory medicine.
[16] D. Gouma,et al. Extended lymph-node dissection for gastric cancer. , 1999, The New England journal of medicine.
[17] R. Hruban,et al. Recommendations for the Reporting of Pancreatic Specimens Containing Malignant Tumors , 1999 .
[18] C. Ratto,et al. Accurate lymph-node detection in colorectal specimens resected for cancer is of prognostic significance , 1999, Diseases of the colon and rectum.
[19] F. Bosman,et al. For patients with dukes' B (TNM stage II) colorectal carcinoma, examination of six or fewer lymph nodes is Related to poor prognosis , 1998, Cancer.
[20] C. Compton,et al. Protocol for the examination of specimens removed from patients with carcinoma of the exocrine pancreas: a basis for checklists. Cancer Committee, College of American Pathologists. , 1997, Archives of pathology & laboratory medicine.
[21] M. Brennan,et al. Outcome of treatment for distal bile duct cancer , 1996, The British journal of surgery.
[22] G. Fleuren,et al. Lymph node retrieval in a randomized trial on western-type versus Japanese-type surgery in gastric cancer. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] C. V. D. van de Velde,et al. Lymph node staging standards in gastric cancer. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] P. Hermanek,et al. Two programmes for examination of regional lymph nodes in colorectal carcinoma with regard to the new pN classification. , 1989, Pathology, research and practice.
[25] M. Aljiffry,et al. Evidence-based approach to cholangiocarcinoma: a systematic review of the current literature. , 2009, Journal of the American College of Surgeons.
[26] M. D'Angelica,et al. Intrahepatic and Extrahepatic Biliary Cancer , 2007 .
[27] S. Kitano,et al. Prognostic factors after pancreatoduodenectomy with extended lymphadenectomy for distal bile duct cancer. , 2002, Archives of surgery.
[28] F. Greene. AJCC cancer staging handbook , 2002 .
[29] C. Compton,et al. Impact of number of nodes retrieved on outcome in patients with rectal cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] C. Heffess,et al. Recommendations for the reporting of pancreatic specimens containing malignant tumors. The Association of Directors of Anatomic and Surgical Pathology. , 1999, American journal of clinical pathology.
[31] M. Huguier,et al. [Extended lymph-node dissection for gastric cancer]. , 1999, Chirurgie; memoires de l'Academie de chirurgie.
[32] G. Fleuren,et al. Surgical/pathologic-stage migration confounds comparisons of gastric cancer survival rates between Japan and Western countries. , 1995, Journal of Clinical Oncology.